Lincoln Pharmaceuticals Ltd reports 30.50% rise in the Standalone Net Profit at Rs. 17.60 crore in Q3 FY22
Highlights:-• Net revenues in Q3 FY22 at Rs. 122.52 crore, up 6.18% from Rs. 115.39 crore in Q3 FY21• Exports (FOB) in 9MFY22 at Rs. 199.78 crore• Over the last 5 years, company has delivered…




